Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.17
-1.69 (-2.96%)
At close: Sep 15, 2026, 4:00 PM EDT
55.89
+0.73 (1.31%)
After-hours: Sep 15, 2026, 7:53 PM EDT
Spruce Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $150 | Buy | Reiterates | $150 | +171.91% | Aug 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $230 | Buy | Reiterates | $230 | +316.93% | Aug 25, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $123 → $104 | Buy | Maintains | $123 → $104 | +88.53% | Aug 17, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $140 | Buy | Maintains | $140 | +153.78% | Aug 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $160 | Buy | Initiates | $160 | +190.04% | Jul 13, 2026 |
| JonesTrading | JonesTrading | Buy Initiates $135 | Buy | Initiates | $135 | +144.72% | Jun 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $140 → $120 | Buy | Reiterates | $140 → $120 | +117.53% | May 15, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $170 → $150 | Buy | Maintains | $170 → $150 | +171.91% | May 14, 2026 |